John Canepa

2021

In 2021, John Canepa earned a total compensation of $449.1K as Chief Financial Officer at Candel Therapeutics, a 66% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$74,000
Salary$370,000
Other$5,123
Total$449,123

Canepa received $370K in salary, accounting for 82% of the total pay in 2021.

Canepa also received $74K in non-equity incentive plan and $5.1K in other compensation.

Rankings

In 2021, John Canepa's compensation ranked 10,948th out of 12,406 executives tracked by ExecPay. In other words, Canepa earned more than 11.8% of executives.

ClassificationRankingPercentile
All
10,948
out of 12,406
12th
Division
Manufacturing
4,822
out of 5,492
12th
Major group
Chemicals And Allied Products
2,158
out of 2,368
9th
Industry group
Drugs
1,919
out of 2,089
8th
Industry
Biological Products, Except Diagnostic Substances
424
out of 452
6th
Source: SEC filing on September 2, 2022.

Canepa's colleagues

We found three more compensation records of executives who worked with John Canepa at Candel Therapeutics in 2021.

2021

Paul FMedSci

Candel Therapeutics

Chief Executive Officer

2021

Estuardo inf

Candel Therapeutics

Chief Executive Officer

2021

Francesca Barone

Candel Therapeutics

Chief Scientific Officer

News

You may also like